Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
8.08
+0.58 (7.73%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $14.14 million as of August 7, 2026. Its market cap has decreased by -56.50% in one year.
Market Cap
14.14M
Enterprise Value
12.11M
1-Year Change
-56.50%
Ranking
Category
Stock Price
$8.08
ChartMarket Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $14.14M, a decrease of -95.15%. That is a compound annual growth rate of -24.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 14.14M | 6.89% |
| Dec 31, 2025 | 13.23M | -59.03% |
| Dec 31, 2024 | 32.30M | 83.11% |
| Dec 29, 2023 | 17.64M | -49.58% |
| Dec 30, 2022 | 34.98M | -51.00% |
| Dec 31, 2021 | 71.40M | 0.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Moolec Science | 14.99M |
| Cyclerion Therapeutics | 14.89M |
| Passage Bio | 14.85M |
| Palatin Technologies | 14.77M |
| KALA BIO | 13.81M |
| BioVie | 13.80M |
| Cocrystal Pharma | 13.51M |
| Tempest Therapeutics | 13.14M |